China Xanthan Gum: Amended Final Results of AD Admin Review
The Commerce Department is amending the final results of an antidumping duty administrative review on xanthan gum from China (A-570-985) to align its revised results with the final decision in a court case that challenged rate calculations in those results. In that review, covering subject merchandise entered July 1, 2019, through June 30, 2020, one company, Neimenggu Fufeng Biotechnologies Co., Ltd. and several affiliates, was given a zero percent AD rate, and three other companies were given rates above de minimis.
Sign up for a free preview to unlock the rest of this article
If your job depends on informed compliance, you need International Trade Today. Delivered every business day and available any time online, only International Trade Today helps you stay current on the increasingly complex international trade regulatory environment.
The original final results were published Feb. 8, 2022, after which the three other companies -- Meihua Group International Trading (Hong Kong) Limited/Langfang Meihua Biotechnology Co., Ltd./Xinjiang Meihua Amino Acid Co., Ltd (collectively, Meihua), Jianlong Biotechnology Co., Ltd. (formerly, Inner Mongolia Jianlong Biochemical Co., Ltd) (Jianlong), and Deosen Biochemical (Ordos) Ltd. -- filed suit; the final results were remanded by the court to Commerce for review in April 2023.
In a final determination in May 2024, Commerce said Meihua's rate for the review period should be zero percent; with that, the separate rate, which applied to two other companies, becomes zero percent for the review period; Deosen Biochemical Ltd. and Deosen Biochemical (Ordos) Ltd. are not a single entity for the purposes of the review period; and therefore, the 2019-2020 administrative review for Deosen Biochemical Ltd. should be rescinded. The Court of International Trade confirmed this final result July 29, 2024.
The original final rate of zero percent for Neimenggu Fufeng and affiliated companies does not change in the revised results.
But the amended results won't change the current cash deposit rate for Meihua, Deosen Biochemical (Ordos) Ltd., and Jianlong because the companies each have a superseding cash deposit rate, i.e., there have been final results published in a subsequent administrative review. Commerce won't issue revised cash deposit instructions to CBP.
Revised rates, which apply for assessment purposes for the period July 1, 2019, through June 30, 2020, are as follows:
| Exporter | Amended AD Rate | Original AD Rate |
|---|---|---|
| Neimenggu Fufeng Biotechnologies Co., Ltd. (aka Inner Mongolia Fufeng Biotechnologies Co., Ltd.) / Shandong Fufeng Fermentation Co., Ltd. / Xinjiang Fufeng Biotechnologies Co., Ltd | not affected | zero |
| Deosen Biochemical Ltd. / Deosen Biochemical (Ordos) Ltd. | no rate / zero (for Ordos only) | 77.04% |
| Meihua Group International Trading (Hong Kong) Limited / Langfang Meihua Biotechnology Co., Ltd. / Xinjiang Meihua Amino Acid Co., Ltd. | zero | 154.07% |
| Jianlong Biotechnology Co., Ltd. (formerly, Inner Mongolia Jianlong Biochemical Co., Ltd) | zero | 77.04% |
(The review period is 07/01/19 - 06/30/20. See Commerce's notice for more information. See 2202070037 for a summary of the original final results of this administrative review.)